Kefeng F. Shen

1095 Jiefang Avenue, Qiaokou District
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

TET2 germline mutation in a patient with sequential lymphoid malignancies: a novel case report.

TET2 germline mutation in a patient with sequential lymphoid malignancies: a novel case report.

Journal: Annals of hematology

Published: July 05, 2025

TNFRSF13B Variant-Induced TACI Dysregulation Underlies CAEBV Pathogenesis.

TNFRSF13B Variant-Induced TACI Dysregulation Underlies CAEBV Pathogenesis.

Journal: Journal of clinical immunology

Published: February 09, 2025

Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles.

Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles.

Journal: Experimental hematology & oncology

Published: December 05, 2024

TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.

TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.

Journal: Clinical epigenetics

Published: October 05, 2024

MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches.

MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches.

Journal: Research and practice in thrombosis and haemostasis

Published: July 08, 2024

A case of Hb M-Iwate combined with diffuse large B-cell lymphoma

A case of Hb M-Iwate combined with diffuse large B-cell lymphoma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 25, 2023

Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma.

Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma.

Journal: Frontiers in immunology

Published: August 19, 2023

Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs).

Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs).

Journal: Blood science (Baltimore, Md.)

Published: July 19, 2023

Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.

Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.

Journal: International journal of cancer

Published: July 12, 2023

Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN.

Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN.

Journal: Frontiers in genetics

Published: April 02, 2023

Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia.

Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia.

Journal: Frontiers in oncology

Published: October 10, 2022

CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease.

CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease.

Journal: Clinical & translational immunology

Published: October 01, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026